Dermatology research Trials

BADBIR Study

British Association of Dermatologists Biological Interventions Register

Principal Investigator: Mel Westmoreland

The purpose of this research study is to assess whether the new biological treatments used in the treatment of psoriasis have any side effects when used long term in real life. These side effects, if any, will be compared to those seen with established treatments such as Ciclosporin , Methotrexate and PUVA (Light Treatment). The study therefore involves following up patients taking a number of different drugs for psoriasis and assessing any possible long-term side effects that may occur.

This study is being funded by the British Association of Dermatologists (BAD), a society of dermatologists aiming to give the best patient care to individuals with skin diseases.

There are currently over 150 hospital sites across the UK and Eire taking part in BADBIR by recruiting participants to join the Register. Once a patient has joined BADBIR, they are followed via their Dermatologist and Research Nurse until 2028 as we assess their clinical details. This is a data-collected study and patients will be asked to complete tick-box questionnaires at their Dermatology appointment. Dermatology participants will be provided with support and the Research Team contact details.

The website is:

British Association of Dermatologists Biologic Interventions Register

More information on BADBIR can be found in both the Participants and Clinicians sections of the website.

BADBIR is based at the University of Manchester and is part of the Arthritis Research UK Epidemiology Unit. Should you ever have any queries on any aspect of the Register please get in touch.

Tel: 0161 306 1896